Vacuolar Protein Sorting (VPS) Inhibitors
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
WZ4003 | 1214265-58-3 | sc-473979 | 5 mg | $300.00 | ||
WZ4003 is a compound that inhibits VPS34 and may indirectly impact VPS26 function within the retromer complex. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $56.00 $256.00 | 113 | |
While primarily known as an autophagy inhibitor, 3-MA can also affect VPS34, indirectly impacting VPS26 function within the retromer complex. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB 202190 is a compound that inhibits p38 mitogen-activated protein kinase (MAPK), and it may have an impact on VPS26 function through downstream signaling pathways. | ||||||
YM201636 | 371942-69-7 | sc-204193 | 5 mg | $213.00 | 6 | |
A PIKfyve inhibitor that affects endosome-to-Golgi retrograde transport, thus impacting VPS proteins involved in this process. | ||||||
SAR405 | 1523406-39-4 | sc-507416 | 1 mg | $125.00 | ||
A VPS34 inhibitor that affects vesicle trafficking and autophagy. | ||||||
Concanamycin A | 80890-47-7 | sc-202111 sc-202111A sc-202111B sc-202111C | 50 µg 200 µg 1 mg 5 mg | $65.00 $162.00 $650.00 $2550.00 | 109 | |
Another V-ATPase inhibitor that interferes with vesicular acidification and therefore VPS function. | ||||||